Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes mellitus this supplement is based on a conference that was held November 6 - 8, 2002, in New York, New York (Excerpta Medica, 2003)
Einzelaufnahme eines Zeitschr.-H.